Maas M, Lambregts DM, Nelemans PJ, Heijnen LA, Martens MH, Leijtens JW, et al. Assessment of clinical complete response after chemoradiation for rectal cancer with digital rectal examination, endoscopy, and MRI: selection for organ-saving treatment. Annals of surgical oncology. 2015;22:3873-80.

Article  PubMed  PubMed Central  Google Scholar 

Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging. CA: a cancer journal for clinicians. 2017;67(2):93-9.

Article  PubMed  Google Scholar 

Kong JC, Soucisse M, Michael M, Tie J, Ngan SY, Leong T, et al. Total neoadjuvant therapy in locally advanced rectal cancer: a systematic review and metaanalysis of oncological and operative outcomes. Annals of Surgical Oncology. 2021;28(12):7476-86.

Article  PubMed  Google Scholar 

Hospers G, Bahadoer RR, Dijkstra EA, van Etten B, Marijnen C, Putter H, et al. Short-course radiotherapy followed by chemotherapy before TME in locally advanced rectal cancer: The randomized RAPIDO trial. American Society of Clinical Oncology; 2020.

Conroy T, Bosset J-F, Etienne P-L, Rio E, François É, Mesgouez-Nebout N, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. The Lancet Oncology. 2021;22(5):702-15.

Article  CAS  PubMed  Google Scholar 

Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CA, Putter H, Kranenbarg EM-K, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. The Lancet Oncology. 2021;22(1):29-42.

Article  CAS  PubMed  Google Scholar 

Habr-Gama A, Gama-Rodrigues J, São Julião GP, Proscurshim I, Sabbagh C, Lynn PB, et al. Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. International Journal of Radiation Oncology* Biology* Physics. 2014;88(4):822–8.

Zhang C, Liang Z, Liu W, Zeng X, Mo Y. Comparison of whole-body 18F-FDG PET/CT and PET/MRI for distant metastases in patients with malignant tumors: a meta-analysis. BMC cancer. 2023;23(1):1-14.

Google Scholar 

Crimi F, Valeggia S, Baffoni L, Stramare R, Lacognata C, Spolverato G, et al. [18F] FDG PET/MRI in rectal cancer. Annals of Nuclear Medicine. 2021;35:281-90.

Article  PubMed  PubMed Central  Google Scholar 

Nensa F, Beiderwellen K, Heusch P, Wetter A. Clinical applications of PET/MRI: current status and future perspectives. Diagn Interv Radiol. 2014;20(5):438-47.

Article  PubMed  PubMed Central  Google Scholar 

Queiroz MA, Ortega CD, Ferreira FR, Nahas SC, Cerri GG, Buchpiguel CA. Diagnostic accuracy of FDG-PET/MRI versus pelvic MRI and thoracic and abdominal CT for detecting synchronous distant metastases in rectal cancer patients. European journal of nuclear medicine and molecular imaging. 2021;48:186-95.

Article  PubMed  Google Scholar 

Grueneisen J, Sawicki LM, Schaarschmidt BM, Suntharalingam S, von der Ropp S, Wetter A, et al. Evaluation of a Fast Protocol for Staging Lymphoma Patients with Integrated PET/MRI. PLOS ONE. 2016;11(6):e0157880.

Article  PubMed  PubMed Central  Google Scholar 

Furtado FS, Suarez-Weiss KE, Vangel M, Clark JW, Cusack JC, Hong T, et al. Clinical impact of PET/MRI in oligometastatic colorectal cancer. British Journal of Cancer. 2021;125(7):975-82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Partovi S, Kohan A, Rubbert C, Vercher-Conejero JL, Gaeta C, Yuh R, et al. Clinical oncologic applications of PET/MRI: a new horizon. American journal of nuclear medicine and molecular imaging. 2014;4(2):202.

PubMed  PubMed Central  Google Scholar 

Bashir U, Mallia A, Stirling J, Joemon J, MacKewn J, Charles-Edwards G, et al. PET/MRI in oncological imaging: state of the art. Diagnostics. 2015;5(3):333-57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine. 2009;6(7):e1000097.

Article  PubMed  PubMed Central  Google Scholar 

Catalano OA, Lee SI, Parente C, Cauley C, Furtado FS, Striar R, et al. Improving staging of rectal cancer in the pelvis: the role of PET/MRI. European Journal of Nuclear Medicine and Molecular Imaging. 2021;48:1235-45.

Article  PubMed  Google Scholar 

Plodeck V, Platzek I, Streitzig J, Nebelung H, Blum S, Kühn J-P, et al. Diagnostic performance of 18F-fluorodeoxyglucose-PET/MRI versus MRI alone in the diagnosis of pelvic recurrence of rectal cancer. Abdominal Radiology. 2021;46(11):5086-94.

Article  PubMed  Google Scholar 

Queiroz MA, Ortega CD, Ferreira FR, Capareli FC, Nahas SC, Cerri GG, et al. Value of primary rectal tumor PET/MRI in the prediction of synchronic metastatic disease. Molecular imaging and biology. 2021:1–11.

Zhou N, Guo X, Sun H, Yu B, Zhu H, Li N, et al. The value of 18F-fdg PET/CT and abdominal PET/MRI as a one-stop protocol in patients with potentially resectable colorectal liver metastases. Frontiers in oncology. 2021;11:714948.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y-N, Lu X, Lu Z-G, Fu L-P, Zhao J, Xiang Z-L. Evaluation of hybrid PET/MRI for gross tumor volume (GTV) delineation in colorectal cancer liver metastases radiotherapy. Cancer Management and Research. 2021:5383–9.

Crimì F, Spolverato G, Lacognata C, Garieri M, Cecchin D, Urso ED, et al. 18F-FDG PET/MRI for rectal cancer TNM restaging after preoperative chemoradiotherapy: initial experience. Diseases of the Colon & Rectum. 2020;63(3):310-8.

Article  Google Scholar 

Li Y, Mueller LI, Neuhaus JP, Bertram S, Schaarschmidt BM, Demircioglu A, et al. 18F-FDG PET/MR versus MR alone in whole-body primary staging and restaging of patients with rectal cancer: what is the benefit of PET? Journal of Clinical Medicine. 2020;9(10):3163.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yoon JH, Lee JM, Chang W, Kang H-j, Bandos A, Lim H-j, et al. Initial M staging of rectal cancer: FDG PET/MRI with a hepatocyte-specific contrast agent versus contrast-enhanced CT. Radiology. 2020;294(2):310-9.

Article  PubMed  Google Scholar 

Amorim BJ, Hong TS, Blaszkowsky LS, Ferrone CR, Berger DL, Bordeianou LG, et al. Clinical impact of PET/MR in treated colorectal cancer patients. European journal of nuclear medicine and molecular imaging. 2019;46:2260-9.

Article  PubMed  Google Scholar 

Ferri V, Vicente Lopez E, Quijano Collazo Y, Caruso R, Duran Gimenez Rico H, Ielpo B, et al. Quantitative analysis of 18-FDG-PET/MRI to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer. A prospective preliminary study. Acta Oncologica. 2019;58(9):1246-9.

PubMed  Google Scholar 

Plodeck V, Rahbari NN, Weitz J, Radosa CG, Laniado M, Hoffmann R-T, et al. FDG-PET/MRI in patients with pelvic recurrence of rectal cancer: first clinical experiences. European Radiology. 2019;29:422-8.

Article  PubMed  Google Scholar 

Rutegård MK, Båtsman M, Axelsson J, Brynolfsson P, Brännström F, Rutegård J, et al. PET/MRI and PET/CT hybrid imaging of rectal cancer–description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) study. Cancer Imaging. 2019;19:1-9.

Article  Google Scholar 

Brendle C, Schwenzer N, Rempp H, Schmidt H, Pfannenberg C, La Fougère C, et al. Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series. European journal of nuclear medicine and molecular imaging. 2016;43:123-32.

Article  CAS  PubMed  Google Scholar 

Kang B, Lee JM, Song YS, Woo S, Hur BY, Jeon JH, et al. Added value of integrated whole-body PET/MRI for evaluation of colorectal cancer: comparison with contrast-enhanced MDCT. American Journal of Roentgenology. 2016;206(1):W10-W20.

Article  PubMed  Google Scholar 

Lee DH, Lee JM, Hur BY, Joo I, Yi N-J, Suh K-S, et al. Colorectal cancer liver metastases: diagnostic performance and prognostic value of PET/MR imaging. Radiology. 2016;280(3):782-92.

Article  PubMed  Google Scholar 

Lee SJ, Seo HJ, Kang KW, Jeong S-Y, Yi N-J, Lee JM, et al. Clinical performance of whole-body 18F-FDG PET/Dixon-VIBE, T1-weighted, and T2-weighted MRI protocol in colorectal cancer. Clinical Nuclear Medicine. 2015;40(8):e392-e8.

Article  PubMed  Google Scholar 

Paspulati RM, Partovi S, Herrmann KA, Krishnamurthi S, Delaney CP, Nguyen NC. Comparison of hybrid FDG PET/MRI compared with PET/CT in colorectal cancer staging and restaging: a pilot study. Abdominal imaging. 2015;40:1415-25.

Article  PubMed  Google Scholar 

Al-Nabhani KZ, Syed R, Michopoulou S, Alkalbani J, Afaq A, Panagiotidis E, et al. Qualitative and quantitative comparison of PET/CT and PET/MR imaging in clinical practice. Journal of Nuclear Medicine. 2014;55(1):88-94.

Article  CAS  PubMed  Google Scholar